ULK1 Inhibition as a Targeted Therapeutic Strategy for Psoriasis by Regulating Keratinocytes and Their Crosstalk With Neutrophils.
ULK1 Inhibition as a Targeted Therapeutic Strategy for Psoriasis by Regulating Keratinocytes and Their Crosstalk With Neutrophils.
复制标题
通过调节角质形成细胞及其与中性粒细胞的串扰,抑制 ULK1 作为银屑病的靶向治疗策略
DOI:
10.3389/fimmu.2021.714274
复制
发表时间:
2021
影响因子:
7.3
通讯作者:
Wang L
中科院分区:
文献类型:
--
作者:
Qiu X;Zheng L;Liu X;Hong D;He M;Tang Z;Tian C;Tan G;Hwang S;Shi Z;Wang L
Psoriasis is a common inflammatory skin disease resulting from an interplay of keratinocytes and immune cells. Previous studies have identified an essential role of autophagy in the maintenance of epidermal homeostasis including proliferation and differentiation. However, much less is known about the role of autophagy-related proteins in the cutaneous immune response. Herein, we showed that ULK1, the key autophagic initiator, and its phosphorylation at Ser556 were distinctively decreased in the epidermis from lesional skin of psoriasis patients. Topical application of SBI0206965, a selective ULK1 inhibitor, significantly attenuated epidermal hyperplasia, infiltration of neutrophils, and transcripts of the psoriasis-related markers in imiquimod (IMQ)-induced psoriasiform dermatitis (PsD). In vitro, ULK1 impairment by siRNA and SBI0206965 arrested cell proliferation and promoted apoptosis of keratinocytes but had a marginal effect on the expression of proinflammatory mediators under steady status. Surprisingly, SBI0206965 blocked the production of chemokines and cytokines in keratinocytes stimulated by neutrophils. Of interest, the pro-apoptotic and anti-inflammatory effects of ULK1 inhibition cannot be fully replicated by autophagic inhibitors. Our findings suggest a self-regulatory process by downregulating ULK1 to maintain the immune homeostasis of psoriatic skin via regulating keratinocytes and their crosstalk with neutrophils, possibly through both autophagy-dependent and independent mechanisms. ULK1 might be a potential target for preventing or treating psoriasis.
登录
查看更多内容
影响因子:
4.6
作者:
Hu SC;Yu HS;Yen FL;Lin CL;Chen GS;Lan CC
通讯作者:
Lan CC
影响因子:
21.3
作者:
通讯作者:
--
DOI:
10.4049/jimmunol.1100123
发表时间:
2011-07-01
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
Lin AM;Rubin CJ;Khandpur R;Wang JY;Riblett M;Yalavarthi S;Villanueva EC;Shah P;Kaplan MJ;Bruce AT
通讯作者:
Bruce AT
DOI:
10.1111/febs.13356
发表时间:
2015-09
期刊:
The FEBS journal
影响因子:
--
作者:
Popelka H;Klionsky DJ
通讯作者:
Klionsky DJ
影响因子:
4.4
作者:
Lee, Hye-Mi;Shin, Dong-Min;Jo, Eun-Kyeong
通讯作者:
Jo, Eun-Kyeong